V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002923 | 330001566 | 1.73 | 81.55 | Curative (C) | 2017-07-17 | 2017-08-07 | Rituximab | N | N | 330011796 | RITUXIMAB |
| 330002924 | 330001566 | 1.64 | null | Disease modification (D) | 2016-05-23 | 2016-05-23 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330011796 | BENDAMUSTINE + RITUXIMAB |
| 330002925 | 330001567 | 1.75 | 66.6 | Disease modification (D) | 2014-01-16 | 2014-01-23 | BENDAMUSTINE + RITUXIMAB | N | N | 330011801 | BENDAMUSTINE + RITUXIMAB |
| 330002929 | 330001569 | 1.94 | 66.8 | Neo-adjuvant (N) | 2015-07-14 | 2015-07-25 | Doxorubicin 75mg/m2 | 02 | N | 330011810 | DOXORUBICIN |
| 330002930 | 330001570 | 1.85 | 50.2 | Not known (9) | 2015-02-21 | 2015-02-22 | Carboplatin AUC 6 - 10 | N | N | 330011812 | CARBOPLATIN |
| 330002931 | 330001571 | null | 4 | Palliative (P) | 2016-09-14 | 2016-09-15 | Bendamustine+Rituximab (1st Course) | y | Y | 330011813 | BENDAMUSTINE + RITUXIMAB |
| 330002932 | 330001571 | 1.64 | 44.2 | Palliative (P) | 2013-11-29 | 2013-12-03 | Liposomal Doxorubicin (20mg/m2) | null | Y | 330011813 | LIPOSOMAL DOXORUBICIN |
| 330002933 | 330001572 | 1.74 | 87.2 | Curative (C) | 2017-07-13 | 2017-07-14 | Rituximab | 2 | N | 330011815 | RITUXIMAB |
| 330002934 | 330001573 | 1.8 | null | Adjuvant (A) | null | 2015-04-01 | CARBOPLATIN + ETOPOSIDE | N | N | 330011817 | CARBOPLATIN + ETOPOSIDE |
| 330002935 | 330001574 | 1.64 | null | Palliative (P) | null | 2014-02-15 | DOXORUBICIN | N | N | 330011818 | DOXORUBICIN |
| 330002936 | 330001574 | 1.68 | 76 | Adjuvant (A) | 2014-03-15 | 2014-03-24 | Doxorubicin 75mg/m2 | 2 | N | 330011818 | DOXORUBICIN |
| 330002937 | 330001574 | 1.73 | 96 | Not known (9) | 2016-07-21 | 2016-08-05 | Cisplatin + Doxorubicin | N | Y | 330011818 | CISPLATIN + DOXORUBICIN |
| 330002938 | 330001574 | 1.5 | 121.4 | Neo-adjuvant (N) | 2016-11-09 | 2016-11-23 | Cisplatin + Doxorubicin | 02 | N | 330011818 | CISPLATIN + DOXORUBICIN |
| 330002939 | 330001574 | 1.5 | 77.4 | Palliative (P) | 2016-02-03 | 2016-05-29 | Liposomal Doxorubicin (20mg/m2) | N | N | 330011818 | LIPOSOMAL DOXORUBICIN |
| 330002940 | 330001574 | 1.6 | null | null | 2015-01-25 | 2015-01-25 | BENDAMUSTINE + RITUXIMAB | N | Y | 330011818 | BENDAMUSTINE + RITUXIMAB |
| 330002943 | 330009691 | 0 | 71.3 | Curative (C) | 2015-03-26 | 2015-03-26 | Carboplatin AUC 2 - 5 | 2 | N | 330011839 | CARBOPLATIN |
| 330002944 | 330009691 | 1.68 | 79.8 | Disease modification (D) | 2016-12-28 | 2017-01-09 | Rituximab | N | N | 330011839 | RITUXIMAB |
| 330002945 | 330009691 | null | 78.6 | Neo-adjuvant (N) | 2016-05-16 | 2016-07-15 | Cisplatin + Doxorubicin | 02 | N | 330011839 | CISPLATIN + DOXORUBICIN |
| 330002946 | 330001576 | 1.8 | 69 | Curative (C) | 2018-04-06 | 2018-04-17 | Liposomal Doxorubicin (20mg/m2) | 2 | N | 330011846 | LIPOSOMAL DOXORUBICIN |
| 330002947 | 330001577 | 1.5 | 79.5 | Curative (C) | 2016-11-27 | 2016-12-05 | Carboplatin AUC 2 - 5 | 02 | N | 330011847 | CARBOPLATIN |
| 330002948 | 330001578 | null | null | Palliative (P) | 2013-05-23 | 2013-05-28 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330011848 | CARBOPLATIN + PACLITAXEL |
| 330002949 | 330001579 | 1.63 | 62 | Palliative (P) | 2014-04-17 | 2014-04-17 | Carboplatin + Etoposide IV 3 day | N | N | 330011849 | CARBOPLATIN + ETOPOSIDE |
| 330002951 | 330001580 | null | 66.8 | Disease modification (D) | 2017-05-10 | 2017-05-15 | Carboplatin + Paclitaxel (weekly) | Y | N | 330011854 | CARBOPLATIN + PACLITAXEL |
| 330002952 | 330006842 | 0.52 | 60.5 | Curative (C) | 2014-10-20 | 2014-10-24 | Liposomal Doxorubicin (20mg/m2) | 2 | N | 330011856 | LIPOSOMAL DOXORUBICIN |
| 330002953 | 330001581 | 1.61 | 103.6 | Disease modification (D) | 2014-07-13 | 2014-09-02 | Liposomal Doxorubicin (20mg/m2) | 2 | N | 330011857 | LIPOSOMAL DOXORUBICIN |
| 330002954 | 330001581 | 1.82 | 74.2 | Palliative (P) | 2017-11-15 | 2017-12-12 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330011857 | LIPOSOMAL DOXORUBICIN |
| 330002955 | 330001582 | 1.7 | 85.9 | Adjuvant (A) | 2017-02-21 | 2017-02-25 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 330011859 | CARBOPLATIN + PACLITAXEL |
| 330002956 | 330001582 | 1.66 | 78 | null | 2018-05-15 | 2018-06-15 | Rituximab | N | Y | 330011859 | RITUXIMAB |
| 330002957 | 330001582 | 1.7 | 91 | null | 2016-08-01 | 2016-08-01 | Rituximab | 02 | N | 330011859 | RITUXIMAB |
| 330002958 | 330001583 | 1.61 | null | Adjuvant (A) | 2015-11-13 | 2015-11-14 | Cisplatin + Doxorubicin | N | N | 330011866 | CISPLATIN + DOXORUBICIN |
| 330002959 | 330001583 | null | 74.8 | Curative (C) | 2017-11-13 | 2017-11-18 | Carboplatin AUC 2 - 5 | 02 | N | 330011866 | CARBOPLATIN |
| 330002960 | 330001583 | 1.67 | 79.1 | Curative (C) | 2013-11-19 | 2014-01-11 | Carboplatin AUC 2 - 5 | N | N | 330011866 | CARBOPLATIN |
| 330002961 | 330001584 | 1.71 | 67.8 | Curative (C) | 2014-07-10 | 2014-07-23 | Carboplatin AUC 2 - 5 | 02 | N | 330011873 | CARBOPLATIN |
| 330002962 | 330006846 | 1.6 | 77 | Curative (C) | 2015-07-08 | 2015-07-08 | Carboplatin AUC 6 - 10 | N | N | 330011874 | CARBOPLATIN |
| 330002963 | 330001585 | 1.55 | 53.4 | Palliative (P) | 2016-06-01 | 2016-06-29 | Cisplatin + Doxorubicin | N | N | 330011877 | CISPLATIN + DOXORUBICIN |
| 330002964 | 330001586 | 1.61 | 68.8 | Adjuvant (A) | 2013-10-27 | 2013-11-16 | Cisplatin + Doxorubicin | 2 | N | 330011878 | CISPLATIN + DOXORUBICIN |
| 330002965 | 330001586 | 1.88 | 50.2 | Not known (9) | 2017-12-26 | 2017-12-27 | Cisplatin + Doxorubicin | N | N | 330011878 | CISPLATIN + DOXORUBICIN |
| 330002966 | 330001586 | 1.82 | 88.6 | Palliative (P) | 2014-11-24 | 2014-11-29 | CARBOPLATIN + ETOPOSIDE | N | N | 330011878 | CARBOPLATIN + ETOPOSIDE |
| 330002967 | 330011271 | 1.7 | 110.3 | Palliative (P) | 2014-03-07 | 2014-03-12 | Liposomal Doxorubicin (20mg/m2) | 2 | N | 330011883 | LIPOSOMAL DOXORUBICIN |
| 330002968 | 330001587 | 1.58 | 59.5 | Palliative (P) | 2016-03-04 | 2016-03-13 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330011884 | BENDAMUSTINE + RITUXIMAB |
| 330002969 | 330001587 | 1.85 | 64.6 | Adjuvant (A) | 2016-03-06 | 2016-03-16 | CARBOPLATIN + PACLITAXEL | N | N | 330011884 | CARBOPLATIN + PACLITAXEL |
| 330002971 | 330006849 | 1.77 | 97.8 | null | 2017-06-20 | 2017-06-30 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330011900 | BENDAMUSTINE + RITUXIMAB |
| 330002972 | 330009695 | 1.61 | 68.6 | Unknown (U) | 2014-10-20 | 2014-10-29 | Rituximab | 2 | N | 330011902 | RITUXIMAB |
| 330002973 | 330001589 | 1.64 | 68.8 | Neo-adjuvant (N) | 2017-11-30 | 2017-11-30 | Carboplatin + Etoposide iv&po | 02 | N | 330011903 | CARBOPLATIN + ETOPOSIDE |
| 330002974 | 330001589 | 0 | 116.9 | Palliative (P) | 2015-10-31 | 2015-10-31 | BENDAMUSTINE + RITUXIMAB | N | N | 330011903 | BENDAMUSTINE + RITUXIMAB |
| 330002975 | 330001589 | 1.62 | 68.2 | Neo-adjuvant (N) | 2016-06-29 | 2016-07-04 | CARBOPLATIN | N | Y | 330011903 | CARBOPLATIN |
| 330002976 | 330001589 | 1.65 | 63.5 | Palliative (P) | 2016-05-03 | 2016-05-14 | Liposomal Doxorubicin (Caelyx) | N | N | 330011903 | LIPOSOMAL DOXORUBICIN |
| 330002977 | 330001589 | 1.78 | 75.6 | Palliative (P) | 2016-04-18 | 2016-04-19 | Carboplatin + Etoposide IV 3 day | 02 | null | 330011903 | CARBOPLATIN + ETOPOSIDE |
| 330002978 | 330001589 | 1.76 | 84 | Palliative (P) | null | 2016-01-31 | Liposomal Doxorubicin (Caelyx) | null | null | 330011903 | LIPOSOMAL DOXORUBICIN |
| 330002979 | 330001589 | 1.79 | 91.1 | Palliative (P) | 2017-09-29 | 2017-10-03 | BENDAMUSTINE + RITUXIMAB | N | N | 330011903 | BENDAMUSTINE + RITUXIMAB |